Not content with resting on our laurels, we decided to spread our business further and better serve our customers in the west. In 2005, we became the first Indian company to acquire an API manufacturing facility outside India , namely, Novus Fine Chemicals in Carlstadt , New Jersey , a US FDA manufacturing facility.

Novus was just the right platform that Malladi needed to bridge the gap between our customers' requirements and our production capabilities. With Novus, we adopted a unique Nearshore/Offshore model with USFDA approved API manufacturing facilities in both the India and USA . Intermediates produced at our manufacturing facilities in India are finished at Novus. Thus we are able to offer our US customers, products manufactured in USA at the cost competitiveness of an Indian Supplier. This arrangement has also helped us cope with the growing international demand for our products with improved service and better relationships.

Novus has a total manufacturing area of 70,000 square feet and over 50,000 gallons of reaction capacity in Stainless Steel, Glass and Hastelloy contact surfaces . It also has a pilot plant to scale-up processes from lab-scale to 500 gallon scale reactor trains. Novus offers total adaptability in production through flexible manufacturing facilities for development, scale-up and commercial manufacture of New Chemical Entities (NCEs), mature Active Pharmaceutical Ingredients (API) and advanced chemical intermediates in a cGMP environment.              Click here for a tour


© Malladi Drugs & Pharmaceuticals Ltd. All rights reserved
Site powered by FINGERPRINTS